An impact of CYP3A4 *1B polymorphism on rifampicin metabolism
Until now, the enzyme systems responsible for biotransformation of the antituberculous drug rifampicin remain unknown. The aim of research was an investigation of the candidate enzymes involved in the biotransformation of rifampicin using the computer system PASS and an experimental study concerning...
Saved in:
Main Authors: | H. O. Poludenko (Author), P. B. Antonenko (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An impact of CYP3A4 *1B polymorphism on rifampicin metabolism
by: H. O. Poludenko, et al.
Published: (2017) -
In Vitro Assessment of the Interaction Potential of Ocimum basilicum (L.) Extracts on CYP2B6, 3A4, and Rifampicin Metabolism
by: Saneesh Kumar, et al.
Published: (2020) -
Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024) -
Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients
by: Caruso A, et al.
Published: (2014) -
Influence of Genetic Polymorphisms in CYP3A5, CYP3A4, and MDR1 on Tacrolimus Metabolism after kidney transplantation
by: Mirgul Bayanova, et al.
Published: (2024)